MAPS Act | ChamberLight

IN COMMITTEE· 119TH CONGRESS

Senate BillS 1784Strategic materials and reservesSupply chain

MAPS Act

INTRO MAY 15· LAST ACTION MAR 19

READING

9MIN

COSPONSORS

7BIPARTISAN

READER REACTIONS0 TOTAL

NO VOTES YET · BE THE FIRST

Introduced only

LEGISLATIVE PROGRESS

STEP 2 / 8

Introduced

In Committee

Reported

Passed Senate

Passed House

Conference

To President

Became Law

WHAT THE BILL DOES

AI-written

This bill matters because it addresses a critical national security and public health concern: the vulnerability of America's drug supply. Many essential medicines and their ingredients are produced overseas, sometimes in countries that could pose a risk if supply lines are disrupted by natural disasters, geopolitical tensions, or even cyberattacks. If this bill becomes law, the government will have a clearer picture of where our vital medicines come from, identify weaknesses, and plan how to prevent shortages.

Without this bill, the U.S. might continue to operate with incomplete knowledge of its pharmaceutical supply chain vulnerabilities. This leaves the country susceptible to shortages of critical drugs, which could have severe consequences for patients, military readiness, and the response to large-scale health emergencies. By proactively mapping and assessing these risks, the bill aims to ensure Americans have consistent access to the medicines they need, regardless of global events.

KEY PROVISIONS

4AI-extracted

PROVISION 01

Requires the Secretary of HHS to update and maintain a list of essential medicines needed for public health, chronic conditions, and national security, at least every two years.

Ensures a clear, updated understanding of which drugs are most critical for the nation's health and security.

PROVISION 02

Mandates a comprehensive risk assessment of the supply chains for these essential medicines, identifying reliance on foreign suppliers, domestic capabilities, and potential security risks.

Pinpoints specific vulnerabilities in the drug supply chain, informing strategies to prevent shortages.

PROVISION 03

Directs HHS to create a system to visually map out these essential medicine supply chains from raw materials to distribution, using data to find weak points.

Provides a dynamic, visual tool to understand and monitor the complex paths essential medicines take, allowing for faster identification of issues.

PROVISION 04

Requires regular reports to Congress and a public version of the supply chain risk assessment findings.

Increases transparency and accountability regarding the government's efforts to secure the drug supply.

SPONSORSHIP

1 + 7

COSPONSOR BREAKDOWNBIPARTISAN · 66%

DEM 2 REP 4 IND 1

ACTION TIMELINE

3 EVENTS

MAR 19

Committee on Health, Education, Labor, and Pensions. Hearings held.

COMMITTEE

MAY 15

Introduced in Senate

INTROREFERRAL

MAY 15

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

INTROREFERRAL

BILL INFO

TypeSenate Bill

NumberS 1784

Congress119th

StatusIn Committee

IntroducedMay 15, 2025

Last actionMar 19, 2026

READER REACTIONS

OVERALL SENTIMENT

No reactions yet. Be the first to weigh in.

Discussion

Loading comments...

Call my reps

IN COMMITTEE· 119TH CONGRESS · HEALTH, EDUCATION, LABOR, AND PENSIONS COMMITTEE · INTRODUCED MAY 15, 2025

Senate BillS 1784Strategic materials and reservesSupply chain

MAPS Act

INTRODUCED MAY 15, 2025· LAST ACTION MAR 19, 2026

PASSAGE CHANCES

—%

READING

9 min

COSPONSORS

COMPLEXITY

Moderate

Call my reps Congress.gov

LEGISLATIVE PROGRESS

STEP 2 OF 8

Introduced

In Committee

Reported

Passed Senate

Passed House

Conference

To President

Became Law

Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law

WHAT THE BILL DOES

AI-written

KEY PROVISIONS

AI-extracted

high

Requires the Secretary of HHS to update and maintain a list of essential medicines needed for public health, chronic conditions, and national security, at least every two years.

Ensures a clear, updated understanding of which drugs are most critical for the nation's health and security.

high

Mandates a comprehensive risk assessment of the supply chains for these essential medicines, identifying reliance on foreign suppliers, domestic capabilities, and potential security risks.

Pinpoints specific vulnerabilities in the drug supply chain, informing strategies to prevent shortages.

med

Directs HHS to create a system to visually map out these essential medicine supply chains from raw materials to distribution, using data to find weak points.

Provides a dynamic, visual tool to understand and monitor the complex paths essential medicines take, allowing for faster identification of issues.

med

Requires regular reports to Congress and a public version of the supply chain risk assessment findings.

Increases transparency and accountability regarding the government's efforts to secure the drug supply.

DEADLINES & DATES

AI-extracted

An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)

Not later than 180 days after the date of enactment.

First updates to the Essential Medicines List.

Not later than 180 days after the date of enactment, and annually thereafter.

Submission of initial report on Essential Medicines Risk Assessment findings to specific Congressional committees and the Office of the Director of National Intelligence.

Not later than 1 year after the date of enactment.

Publication of a public version of the initial risk assessment report.

Not less frequently than every 2 years.

Regular updates to the Essential Medicines List.

GLOSSARY

AI-written

Essential Medicines List: A formal compilation of critical drugs and their key ingredients that are vital for public health, national security, and military preparedness.
Active Pharmaceutical Ingredient (API): The core substance in a drug that produces its intended health effects.
Supply Chain: The entire network of individuals, organizations, resources, activities, and technology involved in the creation and sale of a product, from the delivery of raw materials to the manufacturer through to the end consumer.
Excipient: Inactive substances used as a carrier for the active ingredients of a medication, helping to form the drug's physical characteristics.
Foreign Entity of Concern: A foreign company or individual that has been identified as potentially posing a risk to the national security or foreign policy of the United States.
Data Analytics: The process of examining large sets of information to find patterns, make conclusions, and help in decision-making, often using specialized software and systems.

ACTION TIMELINE

3 EVENTS

MAR 19

Committee on Health, Education, Labor, and Pensions. Hearings held.

COMMITTEE

MAY 15, 25

Introduced in Senate

INTROREFERRAL

MAY 15, 25

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

INTROREFERRAL

READER REACTIONS

0 COMMENTS

WHAT DO YOU THINK?

What do you think?

0 votes

Discussion

Loading comments...

MORE INFORMATION

Committee Referrals

Health, Education, Labor, and Pensions CommitteeReferred

Mar 19, 2026

senate

Related Hearings

Member Day to examine S.297, to amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for prostate cancer screenings without the imposition of cost-sharing requirements, S.380, to improve obstetric emergency care, S.547, to require the Secretary of Health and Human Services and the Secretary of Labor to conduct a study and issue a report on grant programs to support the nursing workforce, S.846, to implement or strengthen programs that increase the supply of quality child care services by enhancing the wages of child care workers, S.864, to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, S.880, to amend the Higher Education Act of 1965 to prohibit institutions of higher education participating in Federal student assistance programs from giving preferential treatment in the admissions process to legacy students or donors, S.942, to amend the Higher Education Act of 1965 to provide for interest-free deferment on student loans for borrowers serving in a medical or dental internship or residency program, S.1269, to promote United States leadership in technical standards by directing the National Institute of Standards and Technology and the Department of State to take certain actions to encourage and enable United States participation in developing standards and specifications for artificial intelligence and other critical and emerging technologies, S.1380, to amend the Public Health Service Act to authorize a loan repayment program to encourage specialty medicine physicians to serve in rural communities experiencing a shortage of specialty medicine physicians, S.1387, to authorize the National Biotechnology Initiative, S.1482, to amend the Public Health Service Act to support and stabilize the existing nursing workforce, establish programs to increase the number of nurses, S.1677, to provide health insurance benefits for outpatient and inpatient items and services related to the diagnosis and treatment of a congenital anomaly or birth defect, S.1756, to amend the Public Health Service Act to prohibit discrimination against health care entities that do not participate in abortion, and to strengthen implementation and enforcement of Federal conscience laws, S.1784, to improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics, S.1813, to amend the Internal Revenue Code of 1986 to allow a credit against tax for charitable donations for the creation or expansion of charter schools, S.1830, to clarify that agencies of the Department of Health and Human Services do not have the authority to regulate the practice of medicine, S.2287, to amend the Public Health Service Act to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools, and other programs, including social work, physician assistant, and chaplaincy education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative and hospice care, S.2289, to amend titles XIX and XXI of the Social Security Act to improve maternal health coverage under Medicaid and CHIP, S.2323, to amend the Head Start Act to permit some teachers in Early Head Start programs to teach while earning a child development associate credential, S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.2531, to authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, S.2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, S.2699, to amend the Public Health Service Act to reauthorize certain education and training programs relating to geriatrics, S.2762, to establish a commission on long-term care, S.2826, to direct the Secretary of Health and Human Services to dedicate sufficient resources for the support of LGBTQ+ youth seeking help from the 9-8-8 suicide prevention hotline, S.2828, to amend the Child Care and Development Block Grant Act of 1990 to reauthorize and update the Act, S.2833, to amend the Older Americans Act of 1965 to improve falls prevention research and activities, S.2841, to amend the American History and Civics Education program under the Elementary and Secondary Education Act of 1965 to require hands-on civic engagement activities for teachers

Health, Education, Labor, and Pensions Committee (senate)Mar 19, 2026

Video

Search

MAPS Act

LEGISLATIVE PROGRESS

WHAT THE BILL DOES

KEY PROVISIONS

SPONSORSHIP

ACTION TIMELINE

BILL INFO

READER REACTIONS

Discussion

MAPS Act

LEGISLATIVE PROGRESS

WHAT THE BILL DOES

KEY PROVISIONS

DEADLINES & DATES

GLOSSARY

ACTION TIMELINE

SPONSORS

READER REACTIONS

What do you think?

Discussion

MORE INFORMATION

Committee Referrals

Related Legislation

Related Hearings